Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SPNS2 inhibitors(sphingolipid transporter 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H35N3O |
InChIKeyZLCZPMKDZPCCEV-UHFFFAOYSA-N |
CAS Registry2764877-61-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Preclinical | US | 02 Jul 2024 | |
Multiple Sclerosis | Preclinical | US | 02 Jul 2024 |